Ephedrine

tripsit

pseudoephedrine

Check on tripsit

tripsit

ephedrine

Check on tripsit

psychonaut

Ephedrine

Check on psychonaut

psychonaut

Pseudoephedrine

Check on psychonaut

isomerdesign

Phenylpropanolmethylamine

Check on isomerdesign

isomerdesign

(1R,2S)-2-(Methylamino)-1-phenylpropan-1-ol

Check on isomerdesign

isomerdesign

(1S,2S)-2-(Methylamino)-1-phenylpropan-1-ol

Check on isomerdesign

pubchem

Pseudoephedrine

Check on pubchem

pubchem

Ephedrine

Check on pubchem

druglab

Éphédrine

Check on druglab

drugmap

Ephedrine

Check on drugmap

drugmap

Ephedrine

Check on drugmap

wiki

Pseudoephedrine

Check on wiki

wiki

Ephedrine

Check on wiki

SMILES:CNC(C)C(O)C1=CC=CC=C1

InChI:InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3

InChI key:KWGRBVOPPLSCSI-UHFFFAOYSA-N

Synonyms: Fedrin,Ephoxamin,d-Pseudoephedrine base,SR-01000075166-1,Ephedrol,SBI-0051498.P003,(1S,2S)-2-(Methylamino)-1-phenylpropan-1-ol, D-psi-2-Methylamino-1-phenyl-1-propanol,Balminil Decongestant Syrup,ephedrine-(racemic), Ephedremal,PDSP1_001347,Lopac0_000501, Ephendronal,AKOS016011257,1(-)ephedrine,Spectrum3_001771,BSPBio_003261,(1s, 2s) pseudoephedrine,HSDB 3177,299-42-3,PSEUDOEPHEDRINE [WHO-DD],DTXSID0023537,PSEUDOEPHEDRINE [MART.],Emerphed (ephedrine sulfate injection),(-)-alpha-(1-Methylaminoethyl)benzyl alcohol,CHEMBL1590,PSEUDOEPHEDRINE HYDROCHLORIDE IMPURITY A [EP IMPURITY],Ephedrine, L-(-)-, Pseudoefedrina [INN-Spanish],(I)-Ephedrin, Ephedrine [USAN:BAN], Zephrol, (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol,Ephedrine l-form,A820118,Acunaso (TN),BIDD:GT0817,(+) threo-2-(methylamino)-1-phenyl-1-propanol,(1S,2S)-(+)-Pseudoephedrine,Acunaso,CCG-204592,(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol, Ephedrine l-form,PDSP2_001327,7CUC9DDI9F, Efidac 24 PseudoephedrineHcl,Ephedrine (USP), Sudafed (TN),CHEBI:51209,EC 202-018-6,Ephedrine (TN), Eciphin,DEA Code 8113,BRD-K84175871-003-02-2,Ephedrin,KBio2_003926, Triaminic Infant Oral Decongestant Drops,I-Sedrin,299E423,(1R,2S)-2-Methylamino-1-phenyl-1-propanol, Alpha-(1-(Methylamino)ethyl)benzyl alcohol,NSC-170951,Ephedrital,AB00375843_06, (1S,2S)-(+)-Pseudoephedrine, L(-)-Ephedrine,Zephrol,NCGC00162174-01,1-Phenyl-1-hydroxy-2-methylaminopropane,Pseudoephedrine, Pseudoephedrine [INN:BAN],DB01364, Nasol, Triaminic AM Decongestant Formula,Efedrin,CS-4802,UNII-7CUC9DDI9F,Isoephedrine,Kratedyn,(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol,C01575,GTPL556,trans-Ephedrine,SPBio_001365,alpha-[1-(Methylamino)ethyl]-benzenemethanol,Biophedrin,EINECS 206-080-5,(1S,2S) pseudoephedrine, (1R,2R)-Ephedrine,Pseudoephedrine (INN),(L)-EPHEDRINE,alpha-Hydroxy-beta-methylaminopropylbenzene,BENZENEMETHANOL, .ALPHA.-(1-(METHYLAMINO)ETHYL)-, (S-(R*,R*))-,(-)-(1R,2S)-Ephedrine,(1S,2S)-2-(Methylamino)-1-phenyl-1-propanol,Neodurasina,l-alpha-(1-Methylaminoethyl)benzyl alcohol,Pseudoephedrinum [INN-Latin], CPDD 0049,Sal-Phedrine,(1S,2S)-(+)-Pseudoephedrine, 98%,L(+)-psi-Ephedrine,1-Sedrin, L-(+)-Ephedrine,PDSP2_001330,Ephedrine [USAN:BAN],Ephedsol, Sudafed Decongestant 12 Hour,Psi-ephedrin,EPHEDRINE [USP MONOGRAPH], Sanedrine,EPHEDRINUM, ANHYDROUS [WHO-IP LATIN], Efedrin,(1R,2S)-(-)-alpha-(1-Methylaminoethyl)benzenemethanol,EPHEDRINE [VANDF],Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alphaS)-,(1R,2S)-(-)-Ephedrine, 98%,NSC170951, Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)-(9CI),IDI1_000451,Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)-,2-Methylamino-1-phenyl-1-propanol, Pseudoephedrine (INN),EPHEDRINE [MART.], L-Ephedrine,Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.R)-,Neodurasina (TN),(1R*,2S*)-2-methylamino-1-phenyl-1-propanol,Pseudoephedrine d-form, Dimetapp Decongestant Pediatric Drops,SBI-0051362.P003,d-psi-Ephedrine,DivK1c_000451,EPHEDRINE HYDROCHLORIDE IMPURITY B [EP IMPURITY], Ephedrital,1-(S),2-(R)-ERYTHRO-(+)-EPHEDRINE,SR-01000075166,1-alpha-(1-Methylaminoethyl)benzyl alcohol,Vencipon,Spectrum2_001303,Sudafed, Mandrin, Pseudoephedrine Ephedrine,AKOS025401512,L-(+)-Pseudoephedrine,(1s, 2s)-(+)-pseudoephedrine,Pseudoephedrinum,(1R,2S)-2-(methylamino)-1-phenyl-1-propanol,CHEBI:15407,(+) pseudoephedrine, (1S,2S)-Pseudoephedrine, polymer-bound,Ephedrine, anhydrous,(+)-psi-Ephedrine,Ephedrinum, anhydrous,(1R,2S)-2-methylamino-1-phenylpropan-1-ol,EPHEDRINE [MI],Pseudoephedrine Ephedrine, Sudafed Decongestant Extra Strength,KBioGR_001763,Nasol,(-)-Ephedrine,SCHEMBL4785,Spectrum_000878,PSEUDOEPHEDRINE [MI],(1R,2S)-(-)-2-(N-methylamino)-1-phenylpropan-1-ol,Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alphaR)-,Benzenemethanol, alpha-(1-(methylamino)ethyl)-, (R-(R*,S*))-,d-Isoephedrine,(1R,2S)-2-(Methylamino)-1-phenylpropan-1-ol,Ephedral,NCGC00178180-01, Ephedsol,(R,S)-2-(Methylamino)-1-phenylpropan-1-ol, (1S,2S)-2-Methylamino-1-phenyl-1-propanol,(1S,2S)-2-methylamino-1-phenylpropan-1-ol, Ephedrine (USP),(.ALPHA.S)-.ALPHA.-((1R)-1-(METHYLAMINO)ETHYL)BENZENEMETHANOL,HSDB 3072,(+)-(1S,2S)-Pseudoephedrine, Ephedral,AI3-02761,(1R,2S)-(-)-2-Methylamino-1-phenyl-1-propanol,ZINC20259,Pseudoefedrina [INN-Spanish],(1R,2S)-1-phenyl-1-hydroxy-2-methylaminopropane,(1R,2S)-2-(methylamino)-1-phenyl-propan-1-ol, Pseudoephedrinum [INN-Latin], Ephedrosan,Isoephedrine, d-,Xenadrine, Fedrin,ZINC74836,PSEUDOEPHEDRINE [VANDF],(R-(R*,S*))-.ALPHA.-(1-(METHYLAMINO)ETHYL)BENZENEMETHANOL [WHO-IP], 1-EPHEDRINE,d-Pseudoephedrine,KBio3_002762,KBioSS_001358,J-500280, (+)-(1S,2S)-Pseudoephedrine, Dimetapp Decongestant,GTPL7286,Lopac-E-3250,EC 206-080-5,Manadrin,(-)-Ephedrine hemisulfate,(1S,2S)-2-Methylamino-1-phenylpropan-1-ol, (1S,2R)-Ephedrine,l-2-Methylamino-1-phenylpropanol,1-2-Methylamino-1-phenylpropanol,pseudophedrine sulphate,90-82-4,(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol,psi-Ephedrine, (+)-,l-Ephedrine,Sanedrine,Pseudoephedrine [INN:BAN],C02765,UNII-GN83C131XS,Benzenemethanol, alpha-(1-(methylamino)ethyl)-, (S-(R*,R*))-,NCI-C55652,Pseudoefedrina,(S,S)-(+)-Pseudoephedrine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,(1S,2S)-Ephedrine,alpha-(1-(Methylamino)ethyl)benzenemethanol,HY-B1195, (+)-Ephedrin,Ephedrotal,alpha-Hydroxy-beta-methyl amine propylbenzene, Lexofedrin,PSEUDOEPHEDRINE,Mandrin,2-(Methylamino)-1-phenyl-1-propanol,DTXSID0022985,L(-)-Ephedrine,racephedrine,(1S,2S)-Pseudoephedrine,Ephendronal,PSEUDOEPHEDRINE [INN], Kratedyn,Besan, Ephedrine (TN),EPHEDRINE [WHO-DD],NCI60_002955,064P256,KBio1_000451,Pseudoephedrine, (+)-,PSEUDOEPHEDRINE [HSDB],Ephedrine,EPHEDRINE [HSDB],NSC 170951,DB00852,Pseudoephedrine (D),NCGC00162174-02,NSC 8971,NINDS_000451,KBio2_006494, (L)-EPHEDRINE,Eciphin, Pseudoephedrine d-form,1-Hydroxy-2-methylamino-1-phenylpropane,SCHEMBL4368, Ephedrotal,Pseudoephedrine polistirex, Vencipon,Spectrum5_000650,Benzenemethanol, alpha-(1-(methylamino)ethyl)-, (-)-,BENZENEMETHANOL, .ALPHA.-(1-(METHYLAMINO)ETHYL)-, (R-(R*,S*))-, Manadrin,alpha-(1-(Methylamino)ethyl)benzyl alcohol,Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.S)-, L-(-)-Ephedrine,EPHEDRINE, ANHYDROUS [WHO-IP], (1S,2S)-Pseudoephedrine,NSC-8971, 1-Sedrin, Ephedrol,Ephedrosan,(1R,2S)-2-Methylamino-1-phenylpropan-1-ol,Pseudoephedrine, L-(+)-,Phenylpropanolmethylamine,D08449,EPHEDRINE [EP MONOGRAPH],CHEMBL211456,(+)-Pseudoephedrine,Spectrum4_001162,d-psi-2-Methylamino-1-phenyl-1-propanol,NCGC00015408-01,1-Phenyl-2-methylaminopropanol,Q219626,Q263958, Ephedrin,Lexofedrin,(+)-threo-Ephedrine,l-Erythro-2-(methylamino)-1-phenylpropan-1-ol,KBio2_001358,Norephedrine, N-methyl-,GN83C131XS, Drixoral Nasal Decongestant,Ephedremal,(1r, 2s)-(-)-ephedrine,EINECS 202-018-6, D-Ephedrine, Ephoxamin,D00124, I-Sedrin, Racephedrine,Psi-ephedrine,BENZENEMETHANOL, .ALPHA.-((1S)-1-(METHYLAMINO)ETHYL)-, (.ALPHA.S)-

Similarities

Being able to identify molecules that are similar to the one we study can allow to infer some of its properties. There are several ways of measuring the similarity between molecules, by their structure, effects, pharmacological interactions etc. In the following, you can find similar molecules according to various criterions and tools that we developed. To understand the limitations of these comparisons, it is crucial to always refer to the methodology that was used to measure those similarities. Please note: This information is provided solely for informational purposes and should not be interpreted as medical advice.

To measure structural similarity, we use the Mol2vec method, which is a neural network that processes molecules and transform them into points in spaces, such that molecules with chemically related substructures are transformed into points that are close in space.

Molecule properties

Using the KGPT Deep Learning model, we predict several property of the molecule. Predictions are grouped by the dataset that was used to get those prediction. Along with each prediction, we provide a plot that shows the distribution of predicted values on the train/test/val dataset. This gives an estimate of the reliability of the model.

Description: A dataset focused on predicting the inhibitory effects of molecules on the enzyme beta-secretase 1 (BACE1). BACE1 inhibition is a potential target for Alzheimer's disease treatment.
Class
TrainValTest
2.88-3.70-1.36
Description: A dataset providing insights on the ability of molecules to penetrate the blood-brain barrier. Crucial for understanding the potential of molecules as central nervous system drugs.
p_np
TrainValTest
-2.24-3.290.40
Description: This dataset deals with the FDA approval status and clinical trial toxicity of molecules. Important for understanding the safety and regulatory status of compounds.
CT_TOX
TrainValTest
-0.49-0.78-0.91
FDA_APPROVED
TrainValTest
0.53-1.27-0.50
Description: A dataset that predicts the solubility of molecules in water. Solubility is an essential property influencing bioavailability and the potential formulation of a drug.
logSolubilitylog(mol/L)
1.10
TrainValTest
Description: This dataset is centered on predicting the free energy when a molecule is dissolved in water. The energy changes can affect molecular interactions in biological systems.
freesolvkcal/mol
-2.20
TrainValTest
Description: A dataset predicting the lipophilicity of molecules. Lipophilicity is a crucial factor affecting the distribution, metabolism, and excretion of drugs in the body.
lipoAlogP
-2.26
TrainValTest
Description: This dataset gives insights into the metabolic stability of molecules. High metabolic stability often results in a longer half-life, influencing drug dosage and frequency.
low
TrainValTest
-0.17-3.50-2.88
high
TrainValTest
0.72-3.55-0.49
27 entries
12 entries
617 entries

Advanced insights

In the following we provide more advanced analysis about the interactions of a molecule with the human metabolism, docking sites etc.

Affinities

Binding affinities with a list of 61 predefined docking sites. Those affinities are used to compute the interactions similarities.

Interaction of this molecule with metabolism

We use a Deep Learning model to predict the interactions of this molecule with metabolism. Refer to the source to understand the methodology.

Reactions that metabolize this molecule
Alkyl-OH-glucuronidation BTMR0165
Enzymes: 2.4.1.17
Reagents

Metabolite: InChI=1S/C16H23...

Sulfation of secondary alcohol BTMR0502
Enzymes: 2.8.2.2
Reagents

Metabolite: InChI=1S/C10H15...

O-Hydroxylation of monosubstituted benzene BTMR1034
Oxidation of secondary alcohol to ketone BTMR0079
Hydroxylation of benzene on carbon para to electron donating group BTMR1047
Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C10H15...

Terminal desaturation BTMR1190
N-Dealkylation of acyclic secondary amine BTMR1140
N-Dealkylation of acyclic secondary amine BTMR1140
N-Dealkylation of acyclic secondary amine BTMR1140
Reactions that metabolism produce from this molecule
N-Dealkylation of acyclic tertiary amine BTMR1142
N-Dealkylation of acyclic tertiary amine BTMR1142
Hydrolysis of carboxylic acid ester BTMR0143
Enzymes: 3.1.1.1
3'-Dehydroxylation of substituted benzene BTMR1314
Enzymes: Unspecified bacterial dehydroxylase
N-Dealkylation of acyclic tertiary amine BTMR1142
Products
4'-Dehydroxylation of substituted benzene BTMR1012
Enzymes: Unspecified bacterial dehydroxylase
Reduction of carbonyl BTMR0368
Enzymes: 1.1.1.184
Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring BTMR1077